Key Market Indicators
Costa Rica’s antidepressant medicine sales are projected to reach $3 million by 2026. In 2021, the country ranked 26th globally, with sales of $2.8 million. This figure represents a 1.3% growth rate from 2012. Latvia was the top performer in 2021, with sales of $2.8 million. Germany, Spain and Italy followed, respectively, in the second, third and fourth positions.
